Literature DB >> 28859040

Successful Treatment of Recurrent Li-Fraumeni Syndrome-related Choroid Plexus Carcinoma.

Matthew McEvoy1, Nathan Robison, Peter Manley, Torunn Yock, Kristine Konopka, Robert E Brown, Johannes Wolff, Adam L Green.   

Abstract

The management of choroid plexus carcinoma (CPC) is challenging and multifaceted. Here, we discuss a 3-year-old girl with CPC and Li-Fraumeni syndrome who achieved full remission after surgery and chemotherapy, with radiation therapy spared. At recurrence, we used a novel, standard-dose cytotoxic chemotherapy regimen, focal proton radiation therapy, and targeted agents based on morphoproteomic analysis to achieve long-term survival. We highlight the rationale for our therapy at recurrence, as well as the risk-benefit analyses necessary in decision making for these patients. Our strategy may be effective in managing other patients with recurrent CPC and Li-Fraumeni syndrome.

Entities:  

Mesh:

Year:  2017        PMID: 28859040      PMCID: PMC5657537          DOI: 10.1097/MPH.0000000000000965

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  20 in total

1.  Radiation therapy and survival in choroid plexus carcinoma.

Authors:  J E Wolff; M Sajedi; M J Coppes; R A Anderson; R M Egeler
Journal:  Lancet       Date:  1999-06-19       Impact factor: 79.321

Review 2.  The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials.

Authors:  Ye-min Wang; Bao-zhe Jin; Fang Ai; Chang-hong Duan; Yi-zhong Lu; Ting-fang Dong; Qing-lin Fu
Journal:  Cancer Chemother Pharmacol       Date:  2012-01-24       Impact factor: 3.333

3.  Choroid plexus carcinoma in children: the Head Start experience.

Authors:  Wafik Zaky; Girish Dhall; Soumen Khatua; Robert J Brown; Kevin F Ginn; Sharon L Gardner; Vedat O Yildiz; Maxim Yankelevich; Jonathan L Finlay
Journal:  Pediatr Blood Cancer       Date:  2015-02-08       Impact factor: 3.167

4.  Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study.

Authors:  Anita Villani; Uri Tabori; Joshua Schiffman; Adam Shlien; Joseph Beyene; Harriet Druker; Ana Novokmet; Jonathan Finlay; David Malkin
Journal:  Lancet Oncol       Date:  2011-05-19       Impact factor: 41.316

5.  Molecular characterization of choroid plexus tumors reveals novel clinically relevant subgroups.

Authors:  Diana M Merino; Adam Shlien; Anita Villani; Malgorzata Pienkowska; Stephen Mack; Vijay Ramaswamy; David Shih; Ruth Tatevossian; Ana Novokmet; Sanaa Choufani; Rina Dvir; Myran Ben-Arush; Brent T Harris; Eugene I Hwang; Rishi Lulla; Stefan M Pfister; Maria Isabel Achatz; Nada Jabado; Jonathan L Finlay; Rosanna Weksberg; Eric Bouffet; Cynthia Hawkins; Michael D Taylor; Uri Tabori; David W Ellison; Richard J Gilbertson; David Malkin
Journal:  Clin Cancer Res       Date:  2014-10-21       Impact factor: 12.531

Review 6.  Novel aspects of mevalonate pathway inhibitors as antitumor agents.

Authors:  Martin Thurnher; Oliver Nussbaumer; Georg Gruenbacher
Journal:  Clin Cancer Res       Date:  2012-04-23       Impact factor: 12.531

7.  Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors.

Authors:  Sharon L Gardner; Shahab Asgharzadeh; Adam Green; Biljana Horn; Geoffrey McCowage; Jonathan Finlay
Journal:  Pediatr Blood Cancer       Date:  2008-08       Impact factor: 3.167

8.  Estimated risk of radiation-induced cancer following paediatric cranio-spinal irradiation with electron, photon and proton therapy.

Authors:  Camilla H Stokkevåg; Grete-May Engeseth; Kristian S Ytre-Hauge; Dieter Röhrich; Odd Harald Odland; Ludvig P Muren; Marianne Brydøy; Liv B Hysing; Artur Szostak; Matthew B Palmer; Jørgen B B Petersen
Journal:  Acta Oncol       Date:  2014-07-14       Impact factor: 4.089

9.  Effects of adjuvant chemotherapy and radiation on overall survival in children with choroid plexus carcinoma.

Authors:  Matthew Z Sun; Michael E Ivan; Michael C Oh; Arthur R Delance; Aaron J Clark; Michael Safaee; Taemin Oh; Gurvinder Kaur; Annette Molinaro; Nalin Gupta; Andrew T Parsa
Journal:  J Neurooncol       Date:  2014-08-09       Impact factor: 4.130

10.  Successful treatment of a recurrent choroid plexus carcinoma with surgery followed by high-dose chemotherapy and stem cell rescue.

Authors:  Othman Mosleh; Uri Tabori; Ute Bartels; Annie Huang; Tal Schechter; Eric Bouffet
Journal:  Pediatr Hematol Oncol       Date:  2013-01-09       Impact factor: 1.969

View more
  2 in total

1.  Molecular insights into malignant progression of atypical choroid plexus papilloma.

Authors:  Maxim Yankelevich; Jonathan L Finlay; Hamza Gorsi; William Kupsky; Daniel R Boue; Carl J Koschmann; Chandan Kumar-Sinha; Rajen Mody
Journal:  Cold Spring Harb Mol Case Stud       Date:  2021-02-19

Review 2.  Inhibiting the Priming for Cancer in Li-Fraumeni Syndrome.

Authors:  Pan Pantziarka; Sarah Blagden
Journal:  Cancers (Basel)       Date:  2022-03-23       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.